Noopept (Powder) — 10 g, Research Grade (RUO)
Noopept (N-phenylacetyl-L-prolylglycine ethyl ester; also known as Omberacetam, GVS-111) is a small-molecule dipeptide analogue supplied by Peptide Tech for laboratory research use only. Each jar contains 10 grams of white crystalline powder produced under GMP-aligned procedures with ≥99% purity (HPLC & MS verified). Trusted by method developers and cell-biology teams, this analyte is suitable for in-vitro, cell-based, and biochemical workflows where identity, purity, and batch traceability matter.
Specifications
| Property | Details |
|---|---|
| CAS Number | 157115-85-0 |
| Chemical Name | N-Phenylacetyl-L-prolylglycine ethyl ester (Omberacetam) |
| PubChem CID | CID 180496 |
| Molecular Formula | C17H22N2O4 |
| Molecular Weight | ≈ 318.37 g/mol |
| Backbone / Type | Dipeptide analogue (Pro–Gly motif); not a linear peptide sequence |
| Physical Appearance | White to off-white crystalline powder |
| Purity | ≥99% verified by HPLC & MS |
| Container | Sealed, light-resistant research jar (10 g net content) with QR batch ID |
| Solubility | Soluble in common polar organic solvents (e.g., ethanol, methanol, DMSO). Assess water solubility empirically and optimize buffer conditions per SOP. |
| Intended Use | Research Use Only (RUO); not for human or animal use, ingestion, diagnostic, or therapeutic applications |
Molecular Structure
Key Features — Peptide Tech
- Same-Day Shipping (Mon–Fri, on in-stock items)
- GMP-Aligned Synthesis & Packaging
- USA Made
- 24/7 Support
- Price Match Guarantee
- Batch-Level Traceability with QR code verification
- 3rd-Party USA Lab Testing — purity, quantity, endotoxin
- Cold-Chain Shipping — Always (no paid upgrade)
- Worldwide Shipping
- All Major Payments Accepted
- Text & Email Order Updates
- 2-Day FedEx/UPS Standard with low-cost Overnight options
- Largest Variety of peptides, peptide analogues & bioregulators (RUO)
Potential Applications in Research
Focus strictly on in-vitro, cellular, biochemical, and analytical contexts. No health claims or human/animal use are implied.
- Cell-based stress pathway readouts — probe HIF-1–linked transcriptional responses with reporter assays (e.g., HEK293 or SH-SY5Y models) under controlled hypoxia-mimetic conditions.
- Neurotoxicity challenge models (in vitro) — evaluate endpoints such as viability, apoptosis markers, ROS, Ca2+ flux, and mitochondrial potential in PC12 or neuronal lines after defined stressors.
- Protein aggregation & biophysical assays — examine effects on in-vitro amyloid oligomerization/aggregation (e.g., α-synuclein) with ThT fluorescence, CD, AFM, and complementary cytometry readouts.
- Excitotoxicity paradigms — use glutamate-exposed neuronal cells (e.g., HT-22) to quantify survival/morphology shifts across concentration–time matrices.
- Mechanistic mapping — interrogate selective transcription factor activity (e.g., HIF-1) vs. other TF panels via luciferase reporters to delineate pathway specificity.
- Analytical method development — develop/validate HPLC or LC-MS/MS methods (ID, assay, stability/forced-degradation, polymorph/solid-state profiling) for small-molecule peptide analogues.
Citations
- Ostrovskaya, R. U., et al. “Neuroprotective Effect of Novel Cognitive Enhancer Noopept on AD-Related Cellular Model Involves the Attenuation of Apoptosis and Tau Hyperphosphorylation.” Journal of Biomedical Science, vol. 21, 2014, article 74. https://pmc.ncbi.nlm.nih.gov/articles/PMC4422191/
- Vakhitova, Y. V., et al. “Molecular Mechanism Underlying the Action of Substituted Pro-Gly Dipeptide Noopept.” Acta Naturae, vol. 8, no. 1, 2016, pp. 82–89. https://pmc.ncbi.nlm.nih.gov/articles/PMC4837574/
- Zainullina, L. F., et al. “Cognitive Enhancer Noopept Activates Transcription Factor HIF-1.” Doklady Biochemistry and Biophysics, vol. 494, no. 1, 2020, pp. 256–260. https://pubmed.ncbi.nlm.nih.gov/33119829/
- Antipova, T. A., et al. “Dipeptide Piracetam Analogue Noopept Improves Viability of Hippocampal HT-22 Neurons in the Glutamate Toxicity Model.” Bulletin of Experimental Biology and Medicine, vol. 161, no. 1, 2016, pp. 58–60. https://pubmed.ncbi.nlm.nih.gov/27265136/
- Jia, X., et al. “Neuroprotective and Nootropic Drug Noopept Rescues α-Synuclein Amyloid Cytotoxicity.” Journal of Molecular Biology, vol. 414, no. 5, 2011, pp. 699–712. https://pubmed.ncbi.nlm.nih.gov/21986202/
- Araj, S. K., et al. “Physicochemical and Structural Analysis of N-Phenylacetyl-L-Prolylglycine Ethyl Ester (Noopept) — An Active Pharmaceutical Ingredient with Nootropic Activity.” Journal of Pharmaceutical and Biomedical Analysis, vol. 252, 2025, 116474. https://pubmed.ncbi.nlm.nih.gov/39298839/
Quality, Storage & Handling
Every lot is confirmed by HPLC (purity) and MS (identity), with QR-linked batch documentation. Third-party U.S. labs verify purity, quantity, and endotoxin.
- Storage (powder): Store sealed, dry, protected from light at 2–8 °C (short term) or ≤−20 °C (long term).
- Handling: Use appropriate PPE and clean-bench technique. Prepare fresh analytical standards; filter if required by your method.
- After dissolution: Aliquot and freeze per SOP; avoid repeated freeze–thaw. Validate solvent compatibility for your assay.
Shipping & Fulfillment
Ships with validated cold-chain packaging. In-stock orders placed before the daily cutoff dispatch the same day. 2-Day FedEx/UPS is standard, with overnight options available. Automated text/email order updates included; international service available where permitted.
Compliance & RUO Disclaimer
For laboratory research use only. Not a drug, food, or cosmetic. Not for human or animal use, ingestion, diagnostic, or therapeutic applications. Purchaser warrants they are qualified to handle RUO materials under applicable laws and institutional policies.
FAQs
- Is this intended for human consumption?
- No. This is a research-use-only material and is not sold for any form of ingestion or therapeutic use.
“`
- What class of compound is Noopept?
- Noopept is a small-molecule dipeptide analogue (Pro–Gly motif). It is not a linear peptide chain.
- Typical lab uses?
- Common applications include in-vitro transcription-factor reporter assays, defined neurotoxicity challenge models, aggregation biophysics, and analytical method development (see citations above).
- How do I access the COA?
- Scan the QR code on the jar for batch details and downloadable documentation.
“`
Explore More
Browse related peptide analogues and research accessories at Peptide Tech.
([PubChem][1])
([PMC][2])
([PMC][3])
([PubMed][4])
([PubMed][5])
([PubMed][6])
[2]: https://pmc.ncbi.nlm.nih.gov/articles/PMC4422191/ ”
Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylation – PMC
”
[3]: https://pmc.ncbi.nlm.nih.gov/articles/PMC4837574/ ”
Molecular Mechanism Underlying the Action of Substituted Pro-Gly Dipeptide Noopept – PMC
”
[4]: https://pubmed.ncbi.nlm.nih.gov/33119829/ “Cognitive Enhancer Noopept Activates Transcription Factor HIF-1 – PubMed”
[5]: https://pubmed.ncbi.nlm.nih.gov/27265136/ “Dipeptide Piracetam Analogue Noopept Improves Viability of Hippocampal HT-22 Neurons in the Glutamate Toxicity Model – PubMed”
[6]: https://pubmed.ncbi.nlm.nih.gov/21986202/ “Neuroprotective and nootropic drug noopept rescues α-synuclein amyloid cytotoxicity – PubMed”













